Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H32N2O5 |
Molecular Weight | 368.4678 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@]1([H])CCCC2)C(O)=O
InChI
InChIKey=IPVQLZZIHOAWMC-RFBLXINOSA-N
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14-,15+,16+/m0/s1
Molecular Formula | C19H32N2O5 |
Molecular Weight | 368.4678 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
(2R,7AR)-2,7A-di-epi-Perindopril is an epimer (R, SR, SS) of the drug perindopril which is commonly used to treat high blood pressure, hypertension, heart failure, or stable coronary artery disease. This form of the drug is much less active.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:41:53 GMT 2023
by
admin
on
Sat Dec 16 10:41:53 GMT 2023
|
Record UNII |
I5I0N5Y7UW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
145513-47-9
Created by
admin on Sat Dec 16 10:41:53 GMT 2023 , Edited by admin on Sat Dec 16 10:41:53 GMT 2023
|
PRIMARY | |||
|
I5I0N5Y7UW
Created by
admin on Sat Dec 16 10:41:53 GMT 2023 , Edited by admin on Sat Dec 16 10:41:53 GMT 2023
|
PRIMARY | |||
|
72941692
Created by
admin on Sat Dec 16 10:41:53 GMT 2023 , Edited by admin on Sat Dec 16 10:41:53 GMT 2023
|
PRIMARY |